DK336776A - Fremgangsmade til fremstilling af hepatitis b immuno-globulin - Google Patents

Fremgangsmade til fremstilling af hepatitis b immuno-globulin

Info

Publication number
DK336776A
DK336776A DK336776A DK336776A DK336776A DK 336776 A DK336776 A DK 336776A DK 336776 A DK336776 A DK 336776A DK 336776 A DK336776 A DK 336776A DK 336776 A DK336776 A DK 336776A
Authority
DK
Denmark
Prior art keywords
globulin
immuno
hepatitis
procedure
preparation
Prior art date
Application number
DK336776A
Other languages
Danish (da)
English (en)
Inventor
W Pollack
A Mckee
Original Assignee
Ortho Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Diagnostics filed Critical Ortho Diagnostics
Publication of DK336776A publication Critical patent/DK336776A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK336776A 1975-07-28 1976-07-26 Fremgangsmade til fremstilling af hepatitis b immuno-globulin DK336776A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/599,619 US4021540A (en) 1975-07-28 1975-07-28 Preparation of a hepatitis B immune globulin and use thereof as a prophylactic material

Publications (1)

Publication Number Publication Date
DK336776A true DK336776A (da) 1977-01-29

Family

ID=24400364

Family Applications (1)

Application Number Title Priority Date Filing Date
DK336776A DK336776A (da) 1975-07-28 1976-07-26 Fremgangsmade til fremstilling af hepatitis b immuno-globulin

Country Status (17)

Country Link
US (1) US4021540A (zh)
JP (1) JPS5215814A (zh)
AU (1) AU512235B2 (zh)
BE (1) BE844566A (zh)
CA (1) CA1069822A (zh)
DE (1) DE2633932A1 (zh)
DK (1) DK336776A (zh)
ES (1) ES450208A1 (zh)
FR (1) FR2319376A1 (zh)
GB (1) GB1548014A (zh)
IL (1) IL50134A (zh)
IT (1) IT1192145B (zh)
NO (1) NO762586L (zh)
PH (1) PH11597A (zh)
PT (1) PT65411B (zh)
SE (1) SE7608475L (zh)
ZA (1) ZA764509B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4174388A (en) * 1977-02-14 1979-11-13 Merck & Co., Inc. Method for preparing hepatitis B immune globulin
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
US4346073A (en) * 1980-04-11 1982-08-24 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis B immune globulin used to inactivate hepatitis B virus in injectable biological products
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
JPS5855432A (ja) * 1981-09-29 1983-04-01 Fujirebio Inc 静脈注射用免疫グロブリンの製法
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4719290A (en) * 1983-09-02 1988-01-12 Armour Pharmaceutical Corporation Composition of intravenous immune globulin
DE4115910A1 (de) * 1991-05-15 1992-11-19 Schweigle Bernhard Dipl Chem Verfahren zur herstellung von nativem, intravenoes verabreichbarem, stabilisiertem immunglobulin
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
AU784808B2 (en) * 2001-04-02 2006-06-29 Kedrion Melville Inc. Prion and viral clearance process
EP1511391B1 (en) * 2002-05-23 2012-05-02 Ortho-Clinical Diagnostics, Inc. Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1539016A (fr) * 1966-06-03 1968-09-13 Ortho Pharma Corp Procédé de production de gobuline anti-rh

Also Published As

Publication number Publication date
IL50134A0 (en) 1976-09-30
CA1069822A (en) 1980-01-15
IL50134A (en) 1979-09-30
BE844566A (fr) 1977-01-27
PT65411A (en) 1976-08-01
ZA764509B (en) 1978-03-29
JPS5215814A (en) 1977-02-05
US4021540A (en) 1977-05-03
PH11597A (en) 1978-03-31
PT65411B (en) 1978-06-09
NO762586L (zh) 1977-01-31
ES450208A1 (es) 1977-08-16
DE2633932A1 (de) 1977-02-17
IT1192145B (it) 1988-03-31
AU512235B2 (en) 1980-10-02
SE7608475L (sv) 1977-01-29
AU1535976A (en) 1978-01-05
FR2319376B1 (zh) 1979-07-13
FR2319376A1 (fr) 1977-02-25
GB1548014A (en) 1979-07-04

Similar Documents

Publication Publication Date Title
DK424476A (da) Fremgangsmade til fremstilling af svovlholdige organosiliciumforbindelser
DK336776A (da) Fremgangsmade til fremstilling af hepatitis b immuno-globulin
DK593975A (da) Fremgangsmade til fremstilling af substituerede perhalogenalkylamidiner
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK535476A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK528976A (da) Fremgangsmade til fremstilling af indazolderivater
DK324176A (da) Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK343976A (da) Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
DK551076A (da) Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK253676A (da) Fremgangsmade til fremstilling af cycloheptathiopenderivater
DK251176A (da) Fremgangsmade til fremstilling af cyklopropanolderivater
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK480676A (da) Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK526676A (da) Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK401476A (da) Fremgangsmade til fremstilling af benzocycloheptapyridinforbindelser
DK141532C (da) Fremgangsmaade til fremstilling af 21-hydroxy-16-pregnen-20-onderivater
DK46476A (da) Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner
DK177176A (da) Fremgangsmade til fremstilling af cyclopentanderivater

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment